Andrew J. Antczak, Ph.D.


Andrew J. Antczak, Ph.D., advises clients on strategic development and monetization of patent portfolios in the areas of life science, digital health, and computer-implemented technologies. Andrew regularly counsels clients on a range of issues overlapping business and intellectual property concerns, including competitive intelligence, freedom to operate opinions, transactional due diligence, and post-grant proceedings, and has experience assisting clients defend and prosecute European opposition matters. He currently sits on the firm’s digital health steering committee.